Dr. Michael Bober
Claim this profileNemours
Studies Achondroplasia
Studies Rhizomelic Chondrodysplasia Punctata
4 reported clinical trials
3 drugs studied
Affiliated Hospitals
Nemours
Nemours, Alfred I DuPont Hospital For Children
More about Michael Bober
Clinical Trial Related11 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Michael Bober has experience with
- Infigratinib
- None
- Registry
Breakdown of trials Michael Bober has run
Rhizomelic Chondrodysplasia Punctata
Chondrodysplasia Punctata
Retinitis Pigmentosa-Cone Rod Dystrophy Syndrome
Retinitis Pigmentosa
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Bober specialize in?
Michael Bober focuses on Achondroplasia and Rhizomelic Chondrodysplasia Punctata. In particular, much of their work with Achondroplasia has involved treating patients, or patients who are undergoing treatment.
Is Michael Bober currently recruiting for clinical trials?
No, Michael Bober is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Michael Bober has studied deeply?
Yes, Michael Bober has studied treatments such as Infigratinib, None, Registry.
What is the best way to schedule an appointment with Michael Bober?
Apply for one of the trials that Michael Bober is conducting.
What is the office address of Michael Bober?
The office of Michael Bober is located at: Nemours, Wilmington, Delaware 19803 United States. This is the address for their practice at the Nemours.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.